Graduate Certificate in Regulatory Science

There is a large and growing need for a well-trained regulatory science workforce to advance the translation of research into clinical interventions.  

This is why the University of Arizona James E. Rogers College of Law is collaborating with the Critical Path Institute (an organization created in partnership with the Food and Drug Administration) and the College of Pharmacy to offer a certificate, which was created by academic and industry leaders to cover real-world issues in regulatory science. 

You will learn what goes into creating and developing medical products, along with the legal practices governing them to make an impact in the biotech and pharmaceutical industry.

Relevant coursework for expertise needed today

All courses provide focused, individualized guidance and feedback as you progress through the program. Over the course of five courses (13 credits) you will:

  • Learn how the FDA is structured and how it regulates drugs, biologics, devices and diagnostics
  • Understand intellectual property and the role of patents in commercialization
  • Explore incentives for medical product development and innovation
  • Navigate the path from clinical trials to bringing a drug to market

Course Offerings

This course navigates the drug development path stretching across the pre-clinical and post-marketing divide to cover the full range of drug regulation, including drug discovery, innovative drug development tools, and the post-approval phase. Intellectual Property protection and evaluation will be covered, along with FDA-enforced market exclusivity and FDA-expedited review programs. The course concludes with international regulatory perspectives, including the European Medicines Agency, the costs involved to bring drugs through the clinical trials to market in the US and abroad, and how this affects future investment and strategy.

There are numerous needs in regulatory science that companies are faced with every day. This course provides an opportunity for students to integrate and apply their knowledge and skills to real-world challenges in regulatory science. Industry leaders will present case-based projects where students will work in teams to discuss and problem-solve multi-faceted issues on a current or emerging topic in regulatory science. Students will consult scientific priority areas and consider strategies for developing new tools and approaches for improvement of safety, efficacy, quality and performance of FDA-regulated products.  

This course explains the ethical principles underlying regulations and guidance governing clinical trials, especially as the principles pertain to informed consent, risk-benefit disclosure, and conflicts of interest. The course also outlines the elements and design of clinical trials, including federal regulations for research with human subject participants, with vulnerable populations, and international research ethics. The course concludes with research ethics in big data.

What are the fundamental incentives for development in the biomedical space? The topics covered in this course include introducing key concepts in oversight by the Food and Drug Administration, biologics and biosimilars, regulation of diagnostics, along with the medical device development and approval process. Proving safety and efficacy in clinical development and promoting innovation through the adoption of new technologies and novel adaptive trial designs will also be discussed. The course concludes with a survey of Intellectual Property rights regime for medical products and the regulatory challenges international markets.

This course explores the intersection of regulation and science, focusing on how regulators at federal and state levels can best accommodate science and how science can best be practiced to satisfy regulators. The course discusses the role of executive agencies such as the Food and Drug Administration (FDA) in ensuring safe and effective products to promote public health, different mechanisms executive agencies use to increase compliance, and current challenges for enforcement in a globalized world.

Tara Sklar, JD, MPH, Professor of Health Law; Director of Graduate Health Sciences Programs: 

"The multidisciplinary faculty designed a unique set of courses where students engage with the regulations governing the development, safety, and efficacy of medical products in the U.S. and abroad." 

From John-Michael Sauer, PhD, Executive Director of the Predictive Safety Testing Consortium at the Critical Path Institute and Professor at University of Arizona

“This program provides a background in how students and professionals can influence and directly participate in the field of Regulatory Science. In connection with our work at the Critical Path Institute, we provide students with the knowledge and tools to accelerate medical product development.”

Online. On your terms

In as few as 12 months, advance your career in the regulatory science field. This flexible program is designed to be completed at your convenience and is 100% online. No entrance exam is required for admission.

Apply Now

Tuition

The University of Arizona James E. Rogers College of Law is one of the most affordable top-tier law schools in the country. Our program is vastly less expensive than most private schools.

The cost is $650 per credit unit (excluding Mandatory University fees). The graduate certificate courses can be applied to the Masters of Legal Studies (upon admission).  Financial aid is available for students in such degree programs.

For further information, please see our brochure.

Key Contact

Tara Sklar

Professor of Health Law; Director of Graduate Health Sciences Programs

trsklar@email.arizona.edu